Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.149
+0.069 (3.33%)
At close: Mar 9, 2026, 4:00 PM EDT
2.150
+0.001 (0.04%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Compugen Market Cap
Compugen has a market cap or net worth of $203.22 million as of March 9, 2026. Its market cap has increased by 4.11% in one year.
Market Cap
203.22M
Enterprise Value
53.05M
1-Year Change
4.11%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $203.22M, an increase of 337.02%. That is a compound annual growth rate of 6.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 196.70M | 37.46% |
| Dec 31, 2025 | 143.10M | 4.45% |
| Dec 31, 2024 | 137.00M | -21.58% |
| Dec 29, 2023 | 174.70M | 181.77% |
| Dec 30, 2022 | 62.00M | -82.82% |
| Dec 31, 2021 | 360.80M | -64.38% |
| Dec 31, 2020 | 1.01B | 183.96% |
| Dec 31, 2019 | 356.70M | 220.49% |
| Dec 31, 2018 | 111.30M | -12.91% |
| Dec 29, 2017 | 127.80M | -50.45% |
| Dec 30, 2016 | 257.90M | -19.68% |
| Dec 31, 2015 | 321.10M | -5.97% |
| Dec 31, 2014 | 341.50M | 4.27% |
| Dec 31, 2013 | 327.50M | 91.74% |
| Dec 31, 2012 | 170.80M | 1.73% |
| Dec 30, 2011 | 167.90M | 3.83% |
| Dec 31, 2010 | 161.70M | 16.92% |
| Dec 31, 2009 | 138.30M | 1,033.61% |
| Dec 31, 2008 | 12.20M | -72.95% |
| Dec 31, 2007 | 45.10M | -37.45% |
| Dec 29, 2006 | 72.10M | -38.95% |
| Dec 30, 2005 | 118.10M | -14.61% |
| Dec 31, 2004 | 138.30M | 4.38% |
| Dec 31, 2003 | 132.50M | 184.95% |
| Dec 31, 2002 | 46.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 203.23M |
| Arcturus Therapeutics Holdings | 202.09M |
| Acumen Pharmaceuticals | 200.50M |
| Galectin Therapeutics | 199.87M |
| Editas Medicine | 195.24M |
| Tenaya Therapeutics | 192.26M |
| NeOnc Technologies Holdings | 188.04M |
| ProQR Therapeutics | 187.51M |